Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diageo plc (DEO) vs Danaher Corporation (DHR) Price & Performance

Diageo plcTrade
Danaher CorporationTrade

Price performance (Past 24H)

Key statistics

Diageo plc vs Danaher Corporation — how do they compare? Diageo plc trades at $94.54 (market cap $53.05B), while Danaher Corporation trades at $206.12 (market cap $145.83B). The key difference: Danaher Corporation is far larger — about 2.7× Diageo plc's market cap, and Diageo plc pays the higher dividend (3.5%). Which is the better fit depends on your goals.

DEODHR
Market Cap
$53.05B$145.83B
Sector
TechnologyHealth
52-Week High
$115.33$242.05
52-Week Low
$72.47$161.91
Enterprise Value
$72.54B$168.04B
Dividend Yield
3.5%0.77%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Diageo plc

No Aura AI signal available yet.

Danaher Corporation

Danaher (DHR) trades at $207.44, up 1.31% today, near its pivot point of $207. The stock exhibits a bullish technical trend, supported by moving averages, though RSI levels suggest overbought conditions. Fundamentally, the company maintains strong profitability with a 58.51% gross margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights the acquisition of Masimo and new product launches from its SCIEX unit, signaling growth initiatives.

The outlook remains positive with analyst consensus favoring a Buy rating and a $202.33 price target, though the current price exceeds this. Risks include a high P/E ratio of 37.32 and ongoing legal settlements, but robust cash flow and institutional accumulation provide support. Earnings growth in the biotechnology segment is a key catalyst for further upside.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Diageo plc

Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.

Read more on DEO

About Danaher Corporation

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.

Read more on DHR